AU714642B2 - G-protein receptor HTNAD29 - Google Patents

G-protein receptor HTNAD29 Download PDF

Info

Publication number
AU714642B2
AU714642B2 AU28204/95A AU2820495A AU714642B2 AU 714642 B2 AU714642 B2 AU 714642B2 AU 28204/95 A AU28204/95 A AU 28204/95A AU 2820495 A AU2820495 A AU 2820495A AU 714642 B2 AU714642 B2 AU 714642B2
Authority
AU
Australia
Prior art keywords
polypeptide
polynucleotide
receptor
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU28204/95A
Other languages
English (en)
Other versions
AU2820495A (en
Inventor
Rebecca A Fuldner
Yi Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2820495A publication Critical patent/AU2820495A/en
Application granted granted Critical
Publication of AU714642B2 publication Critical patent/AU714642B2/en
Priority to AU26430/00A priority Critical patent/AU760468B2/en
Priority to AU2003235001A priority patent/AU2003235001A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
AU28204/95A 1995-06-06 1995-06-06 G-protein receptor HTNAD29 Ceased AU714642B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU26430/00A AU760468B2 (en) 1995-06-06 2000-04-06 G-protein receptor HTNAD29
AU2003235001A AU2003235001A1 (en) 1995-06-06 2003-08-14 G-Protein Receptor HTNAD29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007288 WO1996039442A1 (en) 1995-06-06 1995-06-06 G-protein receptor htnad29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU26430/00A Division AU760468B2 (en) 1995-06-06 2000-04-06 G-protein receptor HTNAD29

Publications (2)

Publication Number Publication Date
AU2820495A AU2820495A (en) 1996-12-24
AU714642B2 true AU714642B2 (en) 2000-01-06

Family

ID=22249278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28204/95A Ceased AU714642B2 (en) 1995-06-06 1995-06-06 G-protein receptor HTNAD29

Country Status (7)

Country Link
EP (1) EP0832126A4 (zh)
JP (1) JPH11506341A (zh)
KR (1) KR19990022531A (zh)
CN (1) CN1147505C (zh)
AU (1) AU714642B2 (zh)
CA (1) CA2221706A1 (zh)
WO (1) WO1996039442A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221627B1 (en) * 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US6733990B1 (en) 1999-08-03 2004-05-11 Millennium Pharmaceuticals, Inc. Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family
EP1676861A3 (en) * 1998-10-13 2006-07-19 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human G protein-coupled receptors
US6919176B2 (en) 2001-05-07 2005-07-19 Amgen Inc. Polypeptides and nucleic acids associated with cancer
WO2003065045A2 (en) * 2002-02-01 2003-08-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with the gpr65 receptor
BRPI0411668A (pt) 2003-06-20 2006-08-08 Novartis Ag receptores acoplados à proteìna g sensìveis a próton e seqüências de dna dos mesmos
WO2008101354A1 (en) * 2007-02-22 2008-08-28 Merck Frosst Canada Ltd Gpr65 as a therapeutic target in allergic airway inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262529A (en) * 1990-01-24 1993-11-16 President And Fellows Of Harvard College Diagnosis of hereditary retinal degenerative diseases
US5462856A (en) * 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
AU655850B2 (en) * 1991-10-01 1995-01-12 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The A method of identifying ligands and antagonists of ligands
AU4855393A (en) * 1992-09-10 1994-03-29 New York University Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PRODEED. NAT. ACAD. SCI., VOL 87 (APRIL 1990) ROSS ET AL. *
SCIENCE, VOL 244 (5 MAY 1989) LIBERT ET AL. *

Also Published As

Publication number Publication date
JPH11506341A (ja) 1999-06-08
WO1996039442A1 (en) 1996-12-12
CN1193980A (zh) 1998-09-23
KR19990022531A (ko) 1999-03-25
AU2820495A (en) 1996-12-24
EP0832126A4 (en) 2000-01-12
CN1147505C (zh) 2004-04-28
CA2221706A1 (en) 1996-12-12
EP0832126A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
US6511826B2 (en) Polynucleotides encoding human G-protein chemokine receptor (CCR5) HDGNR10
US20010000241A1 (en) Antibodies to human G-protein chemokine receptor HDGNR10 (CCR5 receptor)
US20080241124A1 (en) Human G-Protein Chemokine Receptor (CCR5) HDGNR10
US5776729A (en) Human G-protein receptor HGBER32
US20030044898A1 (en) Human G-protein coupled receptors
US20050214281A1 (en) G-protein coupled receptor
US20050266527A1 (en) Human G-protein receptor HIBEF51
AU714642B2 (en) G-protein receptor HTNAD29
US20020106740A1 (en) Human G-protein receptor HPRAJ70
US6338951B1 (en) G-protein parathyroid hormone receptor HLTDG74
US20110112177A1 (en) Human G-Protein Coupled Receptor (HETGQ23)
EP0955808A1 (en) Human g-protein coupled receptor
US20020106741A1 (en) G protein receptor HTNAD29
US20080312178A1 (en) Human G-Protein Receptor HGBER32
CA2220978A1 (en) Human g-protein coupled receptor (hetgq23)
AU760468B2 (en) G-protein receptor HTNAD29
AU716023B2 (en) Human G-protein coupled receptor (HETGQ23)
AU763827B2 (en) Human G-protein coupled receptor (HETGQ23)
US20020086362A1 (en) Human amine receptor
WO1996039441A1 (en) Human g-protein receptor hibef51
US20020106734A1 (en) Adrenergic receptor
US20060014243A1 (en) Human G-protein chemokine receptor HSATU68
EP0832123A1 (en) G-protein parathyroid hormone receptor hltdg74
AU2003235001A1 (en) G-Protein Receptor HTNAD29
AU3535300A (en) Human G-protein coupled receptor (HETGQ23)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)